Healthcare Infection Control Practices Advisory Committee, 28480 [E8-10991]
Download as PDF
<![CDATA[
28480
Federal Register / Vol. 73, No. 96 / Friday, May 16, 2008 / Notices
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Preparedness
and Emergency Response Research
Centers: A Public Health System
Approach, Program Announcement
Number (PA) TP 08–001
sroberts on PROD1PC70 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Times and Dates:
7 p.m.–9:30 p.m., July 7, 2008 (Closed).
8:30 a.m.–5:30 p.m., July 8, 2008 (Closed).
8:30 a.m.–5:30 p.m., July 9, 2008 (Closed).
7 p.m.–9:30 p.m., July 9, 2008 (Closed).
8:30 a.m.–5:30 p.m., July 10, 2008 (Closed).
8:30 a.m.–5:30 p.m., July 11, 2008 (Closed).
Place: Spring Hill Suites Marriott, 3459
Buckhead Loop, Atlanta, GA 30326,
Telephone (404) 844–4800.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Preparedness and Emergency
Response Research Centers: A Public Health
System Approach,’’ PA TP 08–001.
Contact Person for More Information:
Charles Rafferty, Ph.D., Senior Scientific
Review Officer, Office of Science and Public
Health Practice, Coordinating Office for
Terrorism Preparedness and Emergency
Response, CDC, 1600 Clifton Road NE.,
Mailstop D44, Atlanta, GA 30333, Telephone
(404) 639–7495.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Aug<31>2005
16:18 May 15, 2008
Jkt 214001
Dated: May 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–10991 Filed 5–15–08; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee
Dated: May 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–10993 Filed 5–15–08; 8:45 am]
Dated: May 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–10974 Filed 5–15–08; 8:45 am]
Centers for Disease Control and
Prevention
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Statement of Organization, Functions,
and Delegations of Authority
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Name: Healthcare Infection Control
Practices Advisory Committee (HICPAC).
Times and Dates:
9 a.m.–5 p.m., June 12, 2008.
9 a.m.–1 p.m., June 13, 2008.
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, Global
Communications Center, Building 19,
Auditorium B3, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, the Assistant Secretary for Health,
the Director, CDC, and the Director, National
Center for Preparedness, Detection, and
Control of Infectious Diseases (NCPDCID),
regarding (1) the practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Discussed: Guidelines and
progress including prevention of UTI and
Norovirus transmission, HICPAC
prioritization of recommendations for
implementation. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information:
Wendy Vance, HICPAC, Division of
Healthcare Quality Promotion, NCPDCID,
CDC, l600 Clifton Road, NE., Mailstop D–10,
Atlanta, Georgia 30333. Telephone (404)
639–2891.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 73 FR 20297–304, dated
April 15, 2008) is amended to reflect the
reorganization of the Financial
Management Office within the Office of
the Chief Operating Officer, Centers for
Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: Delete in their entirety the titles
and functional statements for the
Financial Management Office (CAJE),
and insert the following:
Financial Management Office (CAJE).
(1) Provides leadership and
coordination in the development and
administration of the Centers for Disease
Control and Prevention’s (CDC)
financial management policies; (2)
develops budget submissions for the
CDC; (3) collaborates with the CDC
Office of the Director (OD) in the
development and implementation of
long-range program and financial plans;
(4) participates in budget reviews and
hearings; (5) manages CDC’s system of
internal budgetary planning and control
of funds; (6) develops and implements
CDC-wide budgetary, accounting, and
fiscal systems and procedures; (7)
conducts CDC-wide manpower
management (including productivity
measurement) activities; (8) prepares
financial reports; (9) serves as the focal
point for domestic and international
travel policy, procedures and
interpretation; (10) provides legislation
reference services; (11) plans, directs
and conducts internal quality assurance
reviews; (12) analyzes data and makes
recommendations to assure effective
safeguards are in place to prevent fraud,
waste and abuse; (13) assists in
identifying or conducting special
E:\FR\FM\16MYN1.SGM
16MYN1
]]>Agencies
[Federal Register Volume 73, Number 96 (Friday, May 16, 2008)]
[Notices]
[Page 28480]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-10991]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
In accordance with section 10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee:
Name: Healthcare Infection Control Practices Advisory Committee
(HICPAC).
Times and Dates:
9 a.m.-5 p.m., June 12, 2008.
9 a.m.-1 p.m., June 13, 2008.
Place: Centers for Disease Control and Prevention, 1600 Clifton
Road, Global Communications Center, Building 19, Auditorium B3,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, the Assistant Secretary for Health, the
Director, CDC, and the Director, National Center for Preparedness,
Detection, and Control of Infectious Diseases (NCPDCID), regarding
(1) the practice of hospital infection control; (2) strategies for
surveillance, prevention, and control of infections (e.g.,
nosocomial infections), antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating
of guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters to be Discussed: Guidelines and progress including
prevention of UTI and Norovirus transmission, HICPAC prioritization
of recommendations for implementation. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information: Wendy Vance, HICPAC,
Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton
Road, NE., Mailstop D-10, Atlanta, Georgia 30333. Telephone (404)
639-2891.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: May 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-10991 Filed 5-15-08; 8:45 am]
BILLING CODE 4163-18-P
